Neurogliovascular unit after cerebral ischemia:: Is the vascular wall a pharmacological target

被引:23
作者
Bastide, M.
Ouk, T.
Plaisier, F.
Petrault, O.
Stolc, S.
Bordet, R.
机构
[1] Fac Med, Pharmacol Lab, F-59045 Lille, France
[2] IUT, BP 179, F-59653 Villeneuve Dascq, France
[3] Slovak Acad Sci, Inst Expt Pharmacol, SK-84104 Bratislava, Slovakia
关键词
cerebral ischemia; cerebral vessel; neurological deficit; potassium channel; pharmacological neuroprotection; pharmacological vasculoprotection;
D O I
10.1016/j.psyneuen.2007.03.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ischemic stroke induces drastic alterations of the functions of the neurogliovascular unit with dramatic consequences on the well-being of the patients in terms of cognitive and motor handicap. Nowadays, only very few therapeutics are available as a treatment of ischemic stroke. Ischemia is a multifactorial pathology involving different cerebral cellular components such as neurons, astrocytes and vessels working as a functional unit. Recent experimental strategy investigation involving different agents with antioxidant properties (dt-BC, stobadine) or pleiotropic effects (lipopolysaccharide, LPS) has been developed to evaluate whether the vascular wall could be considered as a potential. target in neuroprotection concept. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S36 / S39
页数:4
相关论文
共 17 条
[11]   Altered function of inward rectifier potassium channels in cerebrovascular smooth muscle after ischemia/reperfusion [J].
Marrelli, SP ;
Johnson, TD ;
Khorovets, A ;
Childres, WF ;
Bryan, RM .
STROKE, 1998, 29 (07) :1469-1474
[12]   Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion [J].
Pétrault, O ;
Ouk, T ;
Gautier, S ;
Laprais, M ;
Gelé, P ;
Bastide, M ;
Bordet, R .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (08) :1051-1058
[13]   The neuroprotective effect of the antioxidant flavonoid derivate di-tert-butylhydroxyphenyl is parallel to the preventive effect on post-ischemic Kir2.x impairment but not to post-ischemic endothelial dysfunction [J].
Pétrault, O ;
Bastide, M ;
Cotelle, N ;
Gelé, P ;
Gautier, S ;
Laprais, M ;
Vamecq, J ;
Duriez, P ;
Bordet, R .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (05) :395-403
[14]  
PLAISIER F, 2006, FUND CLIN PHARM, V20, P196
[15]   RECOVERY OF FUNCTION AFTER BRAIN-DAMAGE - SEVERE AND CHRONIC DISRUPTION BY DIAZEPAM [J].
SCHALLERT, T ;
HERNANDEZ, TD ;
BARTH, TM .
BRAIN RESEARCH, 1986, 379 (01) :104-111
[16]   Neuroprotection by the pyridoindole stobadine: A minireview [J].
Stolc, S ;
Vlkolinsky, R ;
Pavlasek, J .
BRAIN RESEARCH BULLETIN, 1997, 42 (05) :335-340
[17]   Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms [J].
Zausinger, S ;
Hungerhuber, E ;
Baethmann, A ;
Reulen, HJ ;
Schmid-Elsaesser, R .
BRAIN RESEARCH, 2000, 863 (1-2) :94-105